Preliminary Results from NexImmune’s Phase 1/2 Trial of NEXI-001 in AML Presented at 62nd ASH Annual Meeting and Exposition
Initial data demonstrate early signs of safety, tolerability and robust immune responses in acute myeloid…
News
ALX Oncology Announces Proposed Public Offering of Common Stock
BURLINGAME, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc. (“ALX Oncology”) (Nasdaq:…
Auris Medical Holding to Present at the 13th Annual LD Micro Main Event Conference
Hamilton, Bermuda, December 7, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company…
electroCore to Present at the 13th Annual LD Micro Main Event Conference
BASKING RIDGE, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage…
Agios Announces Updated Data from Phase 1 Study of Mitapivat, First-in-Class PKR Activator, in Sickle Cell Disease
– Treatment with Mitapivat Induced Hemoglobin Increase of ≥1.0 g/dL in 6 of 11 (55%)…
Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
TUSTIN, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated…
Tricida to Provide an End-of-Year Business Update
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical…
Harpoon Therapeutics to Host Clinical Pipeline Programs Update Call and Webcast on December 8, 2020
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP),…
Opiant Pharmaceuticals Announces Appointment of Biopharmaceutical Leader Craig A. Collard as Chairman to its Board of Directors
SANTA MONICA, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a…
Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020
BERWYN, Pa., Dec. 07, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a…